Results 311 to 320 of about 3,221,536 (372)
Some of the next articles are maybe not open access.
Dental Clinics of North America, 2011
Hemostasis is an integral and very important aspect of surgical practice. As a rule, most bleeding from dental surgery can be controlled by pressure. When the application of pressure does not yield satisfactory results, or where more effective hemostasis is required, hemostatic agents are used.
Orrett E, Ogle +2 more
openaire +2 more sources
Hemostasis is an integral and very important aspect of surgical practice. As a rule, most bleeding from dental surgery can be controlled by pressure. When the application of pressure does not yield satisfactory results, or where more effective hemostasis is required, hemostatic agents are used.
Orrett E, Ogle +2 more
openaire +2 more sources
Effects of Algan Hemostatic Agent on bleeding time in a rat tail hemorrhage model.
Ulusal Travma Ve Acil Cerrahi Dergisi-turkish Journal of Trauma & Emergency Surgery, 2020BACKGROUND Algan Hemostatic Agent (AHA) is a multi-herbal extract containing a standardized amount of Achillea millefolium, Juglans regia, Lycopodium clavatum, Rubus caesius or Rubis fruciosus, Viscum album, and Vitis vinifera, each of which is effective
Özgün Melike Gedar Totuk +7 more
semanticscholar +1 more source
Fibrinogen as a Hemostatic Agent
Seminars in Thrombosis and Hemostasis, 2012Coagulation factor I (fibrinogen) plays an essential role in the hemostatic system by bridging activated platelets and being the key substrate for thrombin in establishing a consolidating fibrin network. Fibrinogen is synthesized in the liver and the plasma concentration is 1 to 5-4.0 g/L.
Jonathan H. Foley +6 more
openaire +3 more sources
The journal of obstetrics and gynaecology research, 2020
Laparoscopic myomectomy may be associated with considerable blood loss, especially in patients in whom no specific hemostatic measures are used. We conducted this retrospective comparative study to investigate whether misoprosol is an effective and safe ...
A. Protopapas +9 more
semanticscholar +1 more source
Laparoscopic myomectomy may be associated with considerable blood loss, especially in patients in whom no specific hemostatic measures are used. We conducted this retrospective comparative study to investigate whether misoprosol is an effective and safe ...
A. Protopapas +9 more
semanticscholar +1 more source
Seminars in Thrombosis and Hemostasis, 2015
The mainstay of treatment of inherited coagulation disorders is based on the infusion of the deficient clotting factor, when available. Significant advances have been made over the past two decades in the production and availability of factor replacement products.
Franchini, Massimo +2 more
openaire +4 more sources
The mainstay of treatment of inherited coagulation disorders is based on the infusion of the deficient clotting factor, when available. Significant advances have been made over the past two decades in the production and availability of factor replacement products.
Franchini, Massimo +2 more
openaire +4 more sources
Topical Hemostatic Agents: A Review
Dermatologic Surgery, 2008Topical hemostatic agents play an important role in both common and specialized dermatologic procedures. These agents can be classified based on their mechanism of action and include physical or mechanical agents, caustic agents, biologic physical agents, and physiologic agents.
Jeffrey S. Altman +1 more
openaire +3 more sources
Hemostatic Agents in Orthopedic Surgery
HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery, 2022Controlling blood loss is a crucial aspect of orthopedic surgery. Hemostatic agents can be used intraoperatively in combination with antifibrinolytics as part of an overall strategy to limit blood loss. Several new hemostatic agents have recently come to the market designed specifically for vascular surgery but have found uses in other surgical fields,
Kira K. Tanghe +7 more
openaire +2 more sources
Transfusion-sparing hemostatic agents
Current Opinion in Hematology, 2002A variety of agents are available to improve hemostasis and reduce blood loss in multiple clinical settings. These agents are most commonly used to reduce bleeding when an underlying hemostatic defect is present. Some new agents offer the potential to decrease blood loss even in the absence of an obvious underlying hemostatic defect.
Jason Chiu +2 more
openaire +4 more sources
Microspheres of Carboxymethyl Chitosan, Sodium Alginate, and Collagen as a Hemostatic Agent in Vivo.
ACS Biomaterials Science & Engineering, 2018In the search for biocompatible composite microspheres to be used as a hemostatic agent, in a previous study, we designed a novel biomaterial, consisting of composite microspheres containing three natural biological ingredients, carboxymethyl chitosan ...
Jia Jin +11 more
semanticscholar +1 more source
Degradable and Bioadhesive Alginate-Based Composites: An Effective Hemostatic Agent.
ACS Biomaterials Science & Engineering, 2019The perfect hemostatic material should be capable of rapidly controlling substantial hemorrhaging from visceral organs, veins, and arteries. Ideally, it should be biodegradable, biocompatible, easily applied, and inexpensive. Herein, taking advantages of
He Huang +9 more
semanticscholar +1 more source